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Neutrophils play an integral role in the innate immune system, but robust 
recruitment of these cells can cause collateral host tissue damage. Neutrophils have 
been linked to the severity of a number of pulmonary diseases, including asthma, 
chronic obstructive pulmonary disease, cystic fibrosis, and acute respiratory distress 
syndrome.  These diseases represent a significant economic and health burden, so 
increased understanding of neutrophil chemotaxis is of vital importance. In my 
dissertation, I have utilized molecular biology and mouse models to characterize 
Zfp30, a candidate regulator of the hallmark neutrophil chemokine CXCL1. I 
identified a specific SNP, rs51434084, that underlies a previously identified Zfp30 
eQTL, and I demonstrated the mechanism through which this SNP impacts 
transcription: differential binding of the transcriptional repressor ZFP148. ZFP148 
has a known regulatory role on the neutrophil chemokine CXCL5, and our results 
suggest an additional impact on CXCL1 via Zfp30. 
Additionally, I utilized an ex vivo model of airway epithelial cells generated 
from a Zfp30 knockout mouse strain on a C57BL/6J background to demonstrate that 
Zfp30 significantly modulates CXCL1 and IL-6 secretion in airway epithelial cells.  In 
vivo models utilizing this knockout mouse strain revealed additional effects of Zfp30 
	 iv 
knockout on IL-6 secretion in BALF, liver and spleen development, and blood 
glucose level. These studies explored and confirmed an impact of Zfp30 on the 
secretion of cytokines that modulate airway neutrophilia, and this body of work lays a 
foundation off of which future studies of Zfp30’s impact on development and 
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CHAPTER 1: INTRODUCTION 
Overview and aims 
Neutrophils are an abundant white blood cell population that plays an 
essential role in the innate immune system. They respond to infections with an 
arsenal of pathogen-killing mechanisms, but the activities of these mechanisms are 
largely not pathogen-specific (Henson and Johnston 1987; Weiss 1989).  This 
means that poorly regulated or over-abundant neutrophil activity can lead to host 
tissue damage.  This regulation is particularly important in the lungs and airways, 
because these tissues are constantly exposed to airborne pathogens, pollutants, 
and allergens that represent potential innate immune stimuli.  
Zfp30 emerged from a quantitative trait locus (QTL) mapping study of airway 
inflammation in mice as a candidate gene of interest in modulating neutrophil 
recruitment to the lung through regulation of the chemokine CXCL1 (Rutledge et al. 
2014).  This study identified an expression quantitative trait locus (eQTL) that 
regulated Zfp30 expression and suggested that ZFP30 down-regulates Cxcl1 
through transcriptional repression (Rutledge et al. 2014). The aims of my research 
were to identify the causal variant(s) underlying the Zfp30 eQTL and to further 
characterize the role that Zfp30 plays in neutrophil recruitment to the lungs utilizing 
in vivo, ex vivo, and in vitro approaches. 
In Chapter 2, I utilize molecular biology techniques, including cloning, 
luciferase assays, western blotting, and electrophoretic mobility shift assays to probe 
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the causal variants underlying the Zfp30 eQTL.  These experiments identify 
rs51434084 as a causal variant in the regulation of Zfp30 expression in mice via 
altered binding of the transcription factor ZFP148.  In Chapter 3, I explore the impact 
of ZFP30 loss in mice on multiple baseline phenotypes and on the inflammatory 
response to multiple immune stimuli: house dust mite (HDM) allergen, 
lipopolysaccharide (LPS), and ozone exposure. I additionally make use of ex vivo 
models generated from this mouse strain to probe cytokine responses of LPS 
exposure and find a significant impact on CXCL1 and IL-6 production. In Chapter 4, I 
reflect on the implications and impact of my results and discuss some of the 
nuances of my findings. 
Overview of neutrophils  
An innate immune response is typically initiated by soluble signals associated 
with pathogens, host damage, or both (Nathan 2002). These initial signals to mount 
a response are sensed by resident mast cells and macrophages of a tissue, and 
these cells secrete pro-inflammatory signals to recruit additional leukocytes. 
Neutrophils are a major population among these recruited cells.  
Neutrophil migration to sites of damage or infection typically proceeds through 
a stepwise process that begins with rolling and adhesion of circulating neutrophils to 
activated endothelial tissue (von Andrian et al. 1991; Butcher 1991; Springer 1994). 
From this point, neutrophils polarize to achieve a leading edge with concentrated 
chemokine receptors, and gradients of chemotactic molecules guide neutrophils into 
the tissue through haptotaxis (Middleton et al. 2002; Handel et al. 2005; Wang et al. 
2005). Chief among the chemokines that direct neutrophil migration are the CXCR2 
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ligands (Charo and Ransohoff 2006). CXCR2 is a G-protein-coupled rector 
expressed on a number of cell types, including leukocytes, endothelial cells, and 
epithelial cells in the lung (Stadtmann and Zarbock 2012). CXCL8 (IL-8) (Baggiolini 
et al. 1989), CXCL1 (KC (mice)/Gro-α (human)) (Anisowicz et al. 1987; Richmond et 
al. 1988), CXCL2 (MIP-2 (mice)/Gro-β (human))(Haskill et al. 1990), and CXCL5 
(LIX (mice)/ENA-78 (human)) (Walz et al. 1991) are among the hallmark neutrophil 
recruitment cytokines in humans and mice, though there is no known murine CXCL8 
homolog. 
  Once recruited to the site of inflammation, the phagocytic activity of 
neutrophils increases (Sørensen et al. 2001), and a combination of integrin 
engagement and chemokine stimulation leads to neutrophil respiratory burst (Nathan 
1987).  The generation of reactive oxygen intermediates during respiratory burst is a 
key process in the innate immune system’s antimicrobial response (Nauseef 2007; 
Robinson 2008; Flannagan et al. 2009). A second major antimicrobial mechanism is 
the release of toxic proteins and enzymes, such as myeloperoxidase, neutrophil 
elastase, and defensins via degranulation (Cortjens et al. 2017). The antimicrobial 
activity of neutrophils can even extend beyond the life of the cell itself via neutrophil 
extracellular trap (NET) formation. NETosis is a mechanism of cell death in which 
the nuclear envelope and granule membranes disintegrate, and strands of de-
condensed DNA coated in antimicrobial proteins are extruded from the cell (Fuchs et 
al. 2007). The formation of NETs is thought to be a last line of defense via which 
neutrophils can catch and destroy nearby pathogens (Brinkmann et al. 2004).  
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 Careful balance of neutrophil recruitment is important, as impaired neutrophil 
recruitment to sites of inflammation can lead to unchecked infections, as seen in 
leukocyte adhesion deficiency (Abram and Lowell 2009), and an overzealous 
recruitment of neutrophils can lead to host tissue damage. Much of the neutrophil’s 
armory of antimicrobial mechanisms lacks specificity to pathogens and represents a 
potential source of collateral host tissue damage during a robust response (Nathan 
2006). In addition to direct impacts on host tissue, neutrophils secrete a broad 
repertoire of cytokines to recruit additional leukocytes to sites of infection, and they 
participate in complex cross-talk with multiple immune cell types (Mantovani et al. 
2011). To better understand how a neutrophilic response may minimize collateral 
damage without compromising response to invading microbes, further study of the 
tight regulation of neutrophil recruitment is vital. 
Neutrophils in pulmonary disease 
The literature points to a broad importance of airway neutrophilia in 
pulmonary disease severity, so the regulation of neutrophil recruitment is a vital area 
for study. Acute respiratory distress syndrome (ARDS) is a disease of lung damage 
that can include diffuse alveolar damage, neutrophil alveolitis, edema, and 
hemorrhage (Reilly 2017).  Clinical risk factors alone are poor predictors of patients 
that will develop or survive ARDS, and it is thought to be a complex disease in which 
many genetic variants each confer a small amount of risk (Reilly 2017). Neutrophils 
play a clear role in the pathogenesis of ARDS, with neutrophil-associated gene 
expression levels and neutrophil chemotaxis levels corresponding to increased 
epithelial permeability, edema, and disease progression (Chollet-Martin et al. 1992; 
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Grommes and Soehnlein 2011; Williams and Chambers 2014; Kangelaris et al. 
2015).  
Chronic obstructive pulmonary disease (COPD) is a progressive disease of 
the small airways characterized by persistent airflow limitation and a chronic 
inflammatory response (Vestbo et al. 2013). Smoking is the major risk factor for 
development of COPD, but non-smokers may develop COPD and it is believed that 
genetics may play a role in disease development (Vestbo et al. 2013). Chronic lower 
respiratory diseases, primarily COPD, were the third leading cause of death in the 
United States in 2014 (National Center for Health Statistics 2016), and COPD 
impacts an estimated 6.5 percent of people in the United States (Ford et al. 2015). In 
2010, medical costs associated with COPD were estimated at $32.1 billion, and this 
was projected to increase to $49 billion in 2020 (Ford et al. 2015). A neutrophilic 
infiltrate in the airways and elevated CXCR2 chemokine levels are associated with 
the pathology of COPD and disease severity, and the activity of neutrophil proteases 
and NETs are associated with tissue damage and declining lung function (Qiu et al. 
2003; Quint and Wedzicha 2007; Hoenderdos and Condliffe 2013; Günay et al. 
2014; Duman et al. 2015; Grabcanovic-Musija et al. 2015).  
Cystic Fibrosis (CF) is an often fatal autosomal recessive genetic disorder 
that impacts a chloride conducting transmembrane channel (Elborn 2016). In the 
lungs, this leads to progressive respiratory impairment caused by mucus retention, 
chronic infection, and inflammation (Elborn 2016). In CF, patient sputum has 
considerable neutrophil-stimulating activity, and neutrophil elastase serves as a 
biomarker of disease progression (Mackerness et al. 2008; Gifford and Chalmers 
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2014).  Additionally, aberrant expression of CXCL8 is thought to play a role in CF 
disease severity and is being pursued as a potential drug target (Jundi and Greene 
2015).  Recent evidence suggests that the role of neutrophils in CF may even 
extend beyond their direct mechanisms of antimicrobial toxicity (Laval et al. 2016).  
Asthma is an allergic disease of the lungs and airways with both genetic and 
environmental underpinnings (Whitehead et al. 2003; Kelada et al. 2011; Ober and 
Vercelli 2011; Thomsen 2015). The disease has an increasingly appreciated 
heterogeneity, but the clinical presentation is typically characterized by reversible 
limitation of expiratory airflow, bronchial hyperresponsiveness, and airway 
inflammation (Wenzel 2012). In the United States, asthma impacts 8.3 percent of 
adults and children and costs the nation an estimated $81.9 billion per year (Centers 
for Disease Control 2016; Nurmagambetov et al. 2018). In 2016, asthma lead to 1.7 
million emergency department visits and 3,518 deaths in the United States (Centers 
for Disease Control 2016). Asthma is typically thought of as an eosinophil-dominated 
disease, but in the 1990s, studies of severe asthma spurred interest in the 
heterogeneity of the disease. Many patients with severe asthma exhibit appreciable 
neutrophilia with varying presence of eosinophils, and subsets of inflammatory 
presentation are associated with differing clinical outcomes (Wenzel 2012).  
Neutrophil levels in the lung are associated with asthma disease severity and 
progression, and severe asthmatics show elevated levels of CXCL8 and neutrophil 
myeloperoxidase in sputum (Stănescu et al. 1996; Jatakanon et al. 1999; Wenzel et 
al. 1999; Little et al. 2002).  Severe asthmatics also experience prolonged neutrophil 
survival not solely attributable to inhaled corticosteroid use and display poorer 
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response to glucocorticoids (Green et al. 2002; Uddin et al. 2010), and neutrophil 
levels scale with healthcare utilization among severe asthmatics (Moore et al. 2010).  
There is also accumulating evidence that NETosis contributes to airway obstruction 
in chronic pulmonary diseases, including asthma, COPD, and CF (Cortjens et al. 
2017).  
The importance of CXCR2 signaling in pulmonary disease 
In recognition of the role that neutrophils play in the pathology of pulmonary 
diseases, CXCR2 is being heavily explored as a potential drug target (Jones et al. 
1997; Walters et al. 2008; Chapman et al. 2009; Austin et al. 2015; Ha et al. 2015). 
Promising results from a number of studies suggest tolerability of CXCR2 
antagonists and demonstrate a promising impact on neutrophil recruitment in 
multiple disease contexts (Matzer et al. 2004; Zarbock et al. 2008; Russo et al. 
2009; Lazaar et al. 2011; Virtala et al. 2011; Konrad and Reutershan 2012; Nair et 
al. 2012; Leaker et al. 2013; Moss et al. 2013; Kirsten et al. 2015; Planagumà et al. 
2015; Rennard et al. 2015; Todd et al. 2016; Watz et al. 2017).  Upon CXCR2 
antagonism, a reduction in airway neutrophils is noted in both mild atopic asthmatics 
and patients with severe or persistent neutrophilic asthma (Nair et al. 2012; Todd et 
al. 2016; Watz et al. 2017). Patients with COPD tolerated CXCR2 antagonism well 
with no significant increase in infections and showed fewer neutrophils in sputum 
along with improved forced expiratory volume (FEV1) (Kirsten et al. 2015; Rennard 
et al. 2015), and patients with CF showed improvements in neutrophil counts and 
neutrophil elastase levels in sputum upon CXCR2 antagonism (Moss et al. 2013). 
These results highlight the importance of CXCR2 signaling regulation in contexts 
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where robust neutrophil recruitment may be detrimental and point to the need for 
increased understanding of this pathway’s regulation.  
Overview of the collaborative cross 
 The Collaborative Cross (CC) is a multiparental genetics reference population 
of recombinant inbred strains derived from eight founder strains of inbred mice 
(Collaborative Cross Consortium 2012). The eight founder strains consist of five 
classical inbred strains of mice (A/J, C57BL/6J, 129S1/SvImJ, NOD/ShiLtJ, and 
NZO/HlLtJ) and three wild-derived strains (CAST/EiJ, PWK/PhJ, and WSB/EiJ), and 
these strains represent genetic contributions from three mouse subspecies (M. m. 
musculus, M. m. domesticus, and M. m. castaneum). These founders represent at 
least 36,155,524 single nucleotide polymorphisms (SNPs) between them 
(Collaborative Cross Consortium 2012). The autosomes of the resulting inbred lines 
initially appeared to display similar levels of contribution from each of the CC founder 
strains (Collaborative Cross Consortium 2012), but more recent findings reveal a 
significant depletion in genome-wide haplotype frequencies of CAST/EiJ and 
PWK/PhJ (Srivastava et al. 2017). 
  Genetic reference populations exist for a number of model organisms, and 
they are popular for the study of complex traits (Collaborative Cross Consortium 
2012). These populations are particularly valuable for the ability to design treatment 
vs. control studies or gene/environment interactions across a large number of 
recombinant inbred lines.  The CC advances mouse genetic reference populations 
by increasing the level of genetic diversity above that of previous populations, and it 
displays more uniformly distributed genetic variants across the genome 
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(Collaborative Cross Consortium 2012).  This increased genetic diversity makes the 
CC an ideal population for mapping studies and for the identification of novel mouse 
models of disease. 
Overview of Zinc Finger Proteins 
Zinc finger proteins (ZFPs) with C2H2 domains are the largest family of 
transcription factors in mice and humans (Gray et al. 2004; Vaquerizas et al. 2009). 
C2H2 ZFPs were the first class of ZFPs characterized and are named as such due 
to the Cys(2)His(2) residues that hold a single zinc atom in their structure (Razin et 
al. 2012). These proteins can bind to DNA in a sequence-specific fashion via their 
C2H2 domains, and a large percentage of these ZFPs additionally contain a KRAB 
domain that allows for recruitment of the known transcriptional repressor KAP1 
(Friedman et al. 1996).  KAP1 interacts with HP1, SETDB1, and histone 
deacetylases to induce heterochromatin formation (Ryan et al. 1999; Lechner et al. 
2000; Schultz et al. 2002; Medugno et al. 2005), and these heterochromatin 
domains can spread across tens of kilobases to silence nearby genes (Groner et al. 
2010).  The sequence specificity conferred by C2H2 domains combined with the local 
heterochromatin-mediated silencing mechanism of KAP1 makes C2H2 zinc finger 
proteins potent regulators of gene expression. 
Many ZFPs remain uncharacterized, but there is precedent among known 
ZFPs for regulation of immune response. ZFP36 (TTP) is an important immune 
regulator that impacts the turnover rate of TNFα and GM-CSF messenger RNAs 
(mRNAs) (Patial and Blackshear 2016). ZBTB20 impact the induction of 
inflammatory gene expression in macrophages (Liu et al. 2013). ZFP64 binds to the 
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promoters of TNFα, IL-6, and IFN-β and modulates NF-κB activity (Wang et al. 
2013), and ZFAT is an important transcriptional regulator of immune genes in B and 
T cells (Koyanagi et al. 2008). ZNF160 is a zinc finger protein that down-regulates 
TLR4 in intestinal epithelia via KAP1-mediated heterochromatin domains (Takahashi 
et al. 2009), and Zfp30 is hypothesized to down-regulate Cxcl1 expression via a 
similar mechanism (Rutledge et al. 2014). The overall aim of this dissertation is to 




CHAPTER 2: DIFFERENTIAL REGULATION OF ZFP30 EXPRESSION IN 
MURINE AIRWAY EPITHELIA THROUGH ALTERED BINDING OF ZFP148 TO 
RS514340841 
Introduction 
Recruitment of neutrophils to the lung is a hallmark of innate immune 
responses to inhaled pathogens and air pollutants, and is associated with decreased 
lung function and disease susceptibility (Nathan 2006; Borregaard 2010; Mantovani 
et al. 2011). Neutrophils play an integral role in immune response to external stimuli 
by migrating toward resulting chemotactic signals and responding to pathogens 
through phagocytosis and secretion of reactive oxygen species, proteases, and 
cytokines. These reactive oxygen species and proteases, however, do not 
distinguish between host and pathogen, therefore a robust recruitment of neutrophils 
can adversely impact host tissue. This makes tight regulation of neutrophil 
recruitment and their activity crucial. A neutrophilic infiltrate in the airways is seen in 
a range of pulmonary diseases, including asthma (Jatakanon et al. 1999; Wenzel et 
al. 1999), acute respiratory distress syndrome (ARDS) (Chollet-Martin et al. 1992; 
Grommes and Soehnlein 2011; Williams and Chambers 2014; Kangelaris et al. 
2015), chronic obstructive pulmonary disease (COPD) (Qiu et al. 2003; Quint and 
Wedzicha 2007; Hoenderdos and Condliffe 2013; Günay et al. 2014; Duman et al. 
_____________________ 
 
1Chapter 2 is featured as an article, “Differential Regulation of Zfp30 Expression in 
Murine Airway Epithelia Through Altered Binding of ZFP148 to rs51434084” in G3: 
Genes, Genomes, Genetics, Volume 8, No. 2, Pages 687-693. 
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2015; Grabcanovic-Musija et al. 2015), and cystic fibrosis (CF) (Mackerness et al. 
2008; Gifford and Chalmers 2014; Laval et al. 2016). In asthma, neutrophil levels in 
sputum have been shown to correlate with disease severity and lung function, as 
well as a lack of responsiveness to glucocorticoids (Stănescu et al. 1996; Green et 
al. 2002; Uddin et al. 2010). 
Previously, we applied a house dust mite model of asthma to incipient lines of 
the Collaborative Cross (CC) population to identify novel genes and pathways 
associated with neutrophil recruitment responses in the context of allergic 
inflammation. The CC is a new mouse genetics reference population composed of 
recombinant inbred lines that are derived from eight founder strains (Collaborative 
Cross Consortium 2012). We measured neutrophil recruitment responses and levels 
of the hallmark neutrophil chemokine CXCL1 (aka KC) in bronchoalveolar lavage 
fluid and found that both were regulated by a locus on chromosome 7 (25.6–29.7 
Mb) that we called Dpc1 (Rutledge et al. 2014). Likewise, the expression of the gene 
Zinc finger protein 30 (Zfp30) was also regulated by this locus [i.e., is an expression 
quantitative trait locus (eQTL)], and Zfp30 expression was strongly correlated with 
CXCL1 and neutrophil counts (Figure 2.S1). We also found that Zfp30 is expressed 
in airway epithelia and that knockdown of Zfp30 in an epithelial cell line resulted in 
increased CXCL1 production in response to endotoxin. These results led to 
development of a model in which ZFP30 negatively regulates CXCL1, and CXCL1 
then affects neutrophil recruitment, all under the control of Dpc1. 
Relatively little is known about Zfp30 except that it encodes an as yet 
uncharacterized C2H2 zinc finger protein that contains a Krüppel-associated box 
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Figure 2.S1: Pairwise correlations between Zfp30 expression, CXCL1, and 
neutrophils in incipient CC lines. Plot is derived from previously published data 
(Rutledge et al., 2014). Zfp30 expression is expressed in normalized (log2) units, 
CXCL1 units are log(pg/ml), and neutrophil counts are log10(cell count). Numbers 
above diagonal denote Pearson correlation values, and asterisks denote p-value 

















































domain, signifying a role in gene repression via heterochromatin formation 
(Friedman et al. 1996). However, two features of the Zfp30 eQTL provided important 
insights about Zfp30 regulation. First, allele-specific gene expression data provided 
convincing evidence that the eQTL acts in cis. Second, haplotypes spanning the 5′ 
region of the gene, but not the 3′ region, were strongly correlated with Zfp30 
expression. More specifically, we found that expression levels in CC mice correlated 
strongly with the strain distribution pattern of 5′ region haplotypes: mice with 
haplotypes from NOD/ShiLtJ, NZO/H1LtJ, 129S1/SvImJ, or A/J founder strains had 
high expression; mice with haplotypes from C57BL/6J or WSB/EiJ founder strains 
had moderate expression; and mice with haplotypes from CAST/EiJ or PWK/PhJ 
founder strains had low gene expression. 
These findings prompted us to seek to identify the specific variant(s) that 
regulate Zfp30 expression. In this study, we utilized sequence data, epigenomic 
data, reporter gene assays, and electrophoretic mobility shift assays (EMSA) to 
interrogate the effect that specific variants have on Zfp30 expression. In aggregate, 
our data point to a causal variant responsible for the modulation of Zfp30 
expression, and show that this variant alters transcription factor binding. 
Materials and Methods 
Cell culture 
The MLE12 mouse lung epithelia cell line (generated from FVB/N mouse 
strain) was cultured in a 1:1 mix of Dulbecco’s Modified Eagle Medium and Ham’s 
F12 supplemented with 5% fetal bovine serum (FBS). The LA4 mouse lung airway 
cell line (generated from the A/He mouse strain) was cultured in Ham’s F12K 
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medium supplemented with 15% FBS. Both cell lines were grown at 37° with 5% 
CO2. Twenty-four-well plates were seeded at a density of 120,000 cells per well for 
MLE12 or 125,000 cells per well for LA4 24 hr prior to transfection for luciferase 
assays. 
Dual luciferase reporter assay 
A 500 basepair (bp) genomic region of the Zfp30 promoter surrounding a 
euchromatic region containing a variant of interest was amplified from five of the 
eight CC founder strains. Amplified candidate promoters were subcloned into the 
multiple cloning site upstream of the firefly luciferase gene in the promoterless 
pGL4.10 vector (Promega, Madison, WI) using a Gateway subcloning approach, and 
then verified by sequencing. MLE12 or LA4 cell lines were cotransfected in 24-well 
cell culture plates with 500 ng of candidate promoter constructs and 28 ng 
of Renilla control vector pRL-SV40 (Promega), using Lipofectamine 3000 (Life 
Technologies, Carlsbad, CA), according to manufacturer’s protocol. Transfected 
cells were cultured 48 hr before cell lysates were collected. Luciferase activity was 
measured using the Dual Luciferase Assay System (Promega). Firefly luciferase 
activity was normalized to Renilla luciferase activity as a control for transfection 
efficiency. Data are reported as the ratio of firefly to Renilla luciferase activity, and 
these data are provided in Table S12. Assays include four replicates for each 
candidate promoter and two technical replicates for each lysate collected. Luciferase 
assays were performed in each cell line at least two times, and results were  
_____________________ 
 
2Table S1 is available online at: 
http://www.g3journal.org/content/8/2/687.supplemental 
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consistent across experiments. Welch’s two-sided t-tests were performed to 
compare luciferase activity between promoter constructs. 
Quantitative Polymerase Chain Reaction (qPCR) of luc2 and Renilla luciferase 
mRNA expression of firefly and Renilla luciferase was assayed in MLE12 
RNA samples collected 48 hr post-transfection with candidate promoters and pRL-
SV40. iTaq Universal SYBR Green Supermix (Bio-Rad, Hercules, CA) was used in 
conjunction with luc2 primers (Fwd: 5′-GTGGTGTGCAGCGAGAATAG-3′; Rev: 5′-
CGCTCGTTGTAGATGTCGTTAG-3′) or Renilla luciferase primers (Fwd: 
TCACTATAGGCTAGCCACCAT-3′; Rev: 5′-CACTGCGGACCAGTTATCATC-3′). 
We validated the qPCR primers for efficiency by performing assays with serial 
dilutions of template and verifying the expected changes in Cq values. In 
subsequent assays, Renilla luciferase levels were used to normalize luc2 Cq values, 
and fold change in expression of A/J and 129S1/SvImJ over C57BL/6J was 
calculated. 
Identification of genetic variants among CC founder strains 
We utilized the Sanger Mouse Genomes Project variant database (Keane et 
al. 2011) (http://www.sanger.ac.uk/sanger/Mouse_SnpViewer/rel-1505) to identify 
variants within our cloned promoter region, which spans 29783622–29784093 bp on 
chromosome 7. These variants are shown in Table 2.1. 
Site-directed mutagenesis 
Site-directed mutagenesis to change the rs51434084 allele in pGL4.10 
constructs was carried out using the QuikChange II XL Site-Directed Mutagenesis 
Kit (Agilent, Santa Clara, CA) according to manufacturer’s protocol. Primers (Fwd: 
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5′-CCTCCAACCCCCTTCCCGTGACCAAGAGCTAGGGGCC-3′; Rev: 5′-
GGCCCCTAGCTCTTGGTCACGGGAAGGGGGTTGGAGG -3′) were designed to 
mutate the position corresponding to rs51434084 from C to G. 
EMSA 
Complementary 17 bp oligonucleotide probes centered on rs51434084 were 
purchased from (Integrated DNA Technologies, Coralville, IA) for use in EMSA 
experiments. Sequences for the moderate (C57BL/6J) and high (A/J) expression 
haplotypes, respectively, were as follows: Fwd: 5′-CCCTTCCCCTGACCAAGAG-3′; 
Rev: 5′-CTCTTGGTCAGGGGAAGGG-3′; and Fwd: 5′-
CCCTTCCCGTGACCAAGAG-3′; Rev: 5′-CTCTTGGTCACGGGAAGGG-3′. Sets of 
complementary probes were ordered with and without biotin end-labeling (Integrated 
DNA Technologies). Complementary oligos were annealed into double-stranded 
DNA probes at a concentration of 2 pmol/μl by heating complimentary oligos to 95° 
in an annealing buffer (10 mM Tris, 50 mM NaCl; 1 mM EDTA pH 8.0) and cooling 
them to 25° in a thermocycler at a rate of 1° per minute. NE-PER Nuclear and 
Cytoplasmic Extraction Reagents (Thermo Scientific, Waltham, MA) were used to 
collect nuclear protein lysates from MLE12 cells. Protein concentrations were 
quantified using the Pierce BCA Protein Assay (Thermo Scientific). 
EMSA experiments were performed using the LightShift Chemiluminescent 
EMSA Kit (Thermo Scientific) according to the manufacturer’s protocol. DNA–protein 
binding reactions contained 1× binding buffer, 1 μg poly(dIdC), 4 μg nuclear protein 
lysate, 200 fmol biotinylated DNA probe, and water, for a total reaction volume of 20 
μl. Reactions were incubated at room temperature for 30 min prior to gel loading. 
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Reactions including nonbiotinylated probes for DNA competition were incubated with 
45-fold excess unlabeled probe for 25 min prior to addition of biotinylated probe. 
ZFP148 supershift reactions contained either 10 μg (Figure 2.4) or 20 μg (Figure 
2.S3) antibody incubated for 30 min prior to addition of biotinylated probe. Antibodies 
for ZFP148 (Fisher Scientific, Hampton, NH) and KLF4 (Millipore, Burlington, MA) 
were ordered for use in EMSA supershifts. DNA–protein complexes were separated 
on 6% DNA retardation gels (Life Technologies) using 0.5× TBE buffer (Life 
Technologies). Complexes were transferred to Biodyne B Pre-Cut Modified Nylon 
Membranes (Thermo Scientific) and UV cross-linked before chemiluminescent 
detection. 
Transcription factor binding site prediction 
To identify transcription factor binding sites potentially affected by 
rs51434084, we used TRANSFAC 
(http://generegulation.com/pub/programs.html#match) and HOCOMOCO 
(http://opera.autosome.ru/perfectosape/scan/new) prediction tools. Based on EMSA 
results indicating enhanced binding of nuclear proteins to the C57BL/6J allele (vs. 
129S1/SvImJ), we limited our search to putative transcription factor binding sites in 
which the C57BL/6J allele is predicted to bind the transcription factor better than the 
129S1/SvImJ allele. We then performed literature searches on the initial list of 
candidates to prioritize any transcription factors with a known connection to 





Candidate regulatory region for Zfp30 
We sought to identify the causal variant (or variants) responsible for the Zfp30 
cis-eQTL on chromosome 7 we previously identified in whole lung tissue from 
incipient CC lines, which we showed was associated with variation in CXCL1 and 
neutrophil counts in response to allergen challenge (Rutledge et al. 2014). In that 
study, we found that incipient CC lines with chromosome 7 QTL region haplotypes 
from NOD/ShiLtJ, NZO/H1LtJ, 129S1/SvImJ, or A/J strains had high Zfp30 
expression, mice with haplotypes from C57BL/6J or WSB/EiJ founder strains had 
moderate expression, and mice with haplotypes from CAST/EiJ or PWK/PhJ founder 
strains had low gene expression. This same pattern of expression was observed 
among CC founder lines (Table 2.1), indicating that the cis-eQTL is the major 
determinant of Zfp30 expression. 
To identify regulatory regions that may contribute to variation in Zfp30 
expression, we examined Encyclopedia of DNA Elements (ENCODE) data for 
euchromatic regions marked by DNAse I hypersensitivity near the 5′ region of Zfp30 
in mouse lung tissue, because our previous data indicated a strong correlation 
between 5′ region haplotypes and gene expression (Rutledge et al. 2014). We 
examined a region spanning 10 kb upstream through intron 1 and identified a ∼ 500 
bp region of open chromatin near the putative Zfp30 promoter and transcription start 
site (Figure 2.S2), which contains 10 SNPs. An examination of the strain distribution 






























A/J	 7.72	 1.86	 High	 C	 T	 C	 C	 G	 C	 T	 C	 G	 G	
NOD/ShiLtJ	 7.65	 1.77	 High	 C	 T	 C	 C	 G	 C	 T	 C	 G	 G	
NZO/H1LtJ	 7.56	 1.67	 High	 C	 T	 C	 C	 G	 C	 T	 C	 G	 G	
129S1/SvImJ	 7.57	 1.68	 High	 T	 T	 T	 C	 G	 C	 T	 C	 G	 G	
C57BL/6J	 6.82	 1.00 (Ref.)	 Moderate	 T	 T	 T	 C	 G	 C	 T	 C	 G	 C	
WSB/EiJ	 6.69	 0.91	 Moderate	 T	 T	 T	 C	 G	 C	 T	 C	 G	 C	
CAST/EiJ	 6.48	 0.79	 Low	 C	 C	 C	 A	 C	 T	 C	 T	 A	 C	
PWK/PhJ	 6.42	 0.76	 Low	 C	 T	 C	 A	 C	 T	 C	 T	 A	 C	
 
Table 2.1: Zfp30 expression levels among CC founder strains and strain distribution patterns (SDPs) for 5’ region 
SNPs. a: The Sanger Mouse Genomes Project variant database was utilized for SNP data. b: Expression data (log2 units) 








Figure 2.S2: ENCODE Data reveals a candidate regulatory region. DNase I hypersensitivity peaks in mouse lung 
tissue reveal an open region of chromatin and candidate regulatory region. The region cloned for luciferase assays spans 







revealed a single shared SNP (rs51434084) among the high expression strains and 
six shared SNPs among the low-expressing strains (Table 2.1). These variants were 
thus considered priority candidates that might affect regulation of Zfp30 in a manner 
consistent with the three expression groups.	
Candidate regulatory region significantly modulates reporter gene activity in 
mouse airway epithelia cell lines 
To interrogate the effect of this candidate regulatory region on Zfp30 
expression, we cloned the 500 bp putative promoter region from representative 
strains of each Zfp30 expression group into a promoterless luciferase vector for use 
in luciferase reporter assays. More than one strain was chosen from the high and 
low expression groups to account for potential differences in gene expression due to 
variants in the region. Specifically, promoter regions were cloned from A/J and 
129S1/SvImJ to represent the high expression group, from C57BL/6J to represent 
the intermediate expression group, and from CAST/EiJ and PWK/PhJ to represent 
the low expression group. 
We then tested whether these promoter constructs recapitulate relative 
patterns of expression seen in vivo, using luciferase reporter assays in two mouse 
lung epithelia cell lines, MLE12 and LA4. Mouse lung epithelia cell lines were 
chosen because Zfp30 expression was previously reported in this tissue. 
Additionally, we previously reported that knockdown of Zfp30 using small interfering 
RNAs (siRNAs) in MLE12 cells led to increased CXCL1 secretion in response to 
LPS exposure, which is consistent with predictions based on in vivo data (Rutledge 
et al. 2014). Concordant with previously measured in vivo expression data (see 
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Table 2.1), initial luciferase experiments in the MLE12 mouse lung epithelia cell line 
(Figure 2.1A) revealed a significant twofold difference in expression driven by 
promoters from high-expressing strains (A/J and 129S1/SvImJ) compared with 
lower-expressing strains (C57BL/6J, CAST/EiJ, and PWK/PhJ). No difference in 
luciferase activity was observed between the moderate-expressing (C57BL/6J) and 
low-expressing (CAST/EiJ and PWK/PhJ) promoter constructs in this cell line. This 
assay was also performed in the LA4 mouse airway cell line to compare results 
across differing genetic backgrounds. In LA4 cells, the expression difference 
between high and moderate expression groups was also evident, and at a similar 
magnitude. Additionally, CAST/EiJ and PWK/PhJ promoters produced significantly 
lower expression than C57BL/6J promoter (Figure 2.1B), at a magnitude roughly 
equivalent to the in vivo differences shown in Table 1. To verify that the differences 
we observed exist at both the protein and RNA levels, we measured luc2 and Renilla 
luciferase mRNA levels in transfected MLE12 cells using a custom qPCR assay. The 
results, shown in Table 2.S23, confirmed that the difference we observed in protein 
activity was also present at the RNA level. 
We then focused our attention on the identification of SNPs that could explain 
the observed twofold expression difference between moderate and high Zfp30 
expressing promoters, for two reasons. First, the difference between moderate and 
high expression strains is much larger than the expression difference between 
moderate and low expression strains (Table 2.1). Second, in addition to our previous  
_____________________ 
 





Figure 2.1: Zfp30 promoter region haplotypes recapitulate in vivo patterns of 
gene expression in reporter assays. Dual luciferase reporter assays were 
performed, and firefly/Renilla ratios are shown. Reporter clones are grouped by in 
vivo Zfp30 expression level: high (H), moderate (M), and low (L). (A) Results from 
assays in MLE12 cells recapitulate in vivo differences between moderate-expressing 
(C57BL/6J) and high-expressing (A/J and 129S1/SvImJ) strains but not low-
expressing (CAST/EiJ) and (PWK/PhJ) strains. (B) Results from assays in LA4 cells 





finding regarding the link between Zfp30 expression and immune response in the 
lung (Rutledge et al. 2014), a previous report from a different research group 
indicates that the aforementioned expression difference is likely also the cause of 
contrasting response to Streptococcus pneumonia infection (Denny et al. 2003). 
Within the cloned regulatory region, A/J and 129S1/SvImJ share only one 
variant, rs51434084. To test the regulatory effect of this SNP, we used a site- 
directed mutagenesis approach to modify a C57BL/6J promoter at this locus to 
match the allele of the high-expressing strains. The resulting promoter contains a 
single bp modification that results in a doubling of expression in both MLE12 (P < 
0.001) and LA4 (P < 0.05) cell lines (Figure 2.2), matching the expression levels of 
A/J and 129S1/SvImJ. 
Variation at rs51434084 results in differential binding of ZFP148 
We then performed EMSA experiments to detect differential binding of 
transcription factors from MLE12 nuclear lysates to 17 bp probes mimicking either 
the C57BL/6J or 129S1/SvImJ allele at rs51434084 (Figure 2.3). Multiple DNA–
protein complexes were observed for each probe, and each complex showed higher 
affinity for the C57BL/6J probe. Competition reactions with unlabeled probes 
revealed that the unlabeled C57BL/6J probe competed these interactions away with 
higher affinity than the unlabeled 129S1/SvImJ probe. Given that in vivo data and in 
vitro reporter assays both indicated that the C57BL/6J haplotype is associated with 
lower gene expression than the 129S1/SvImJ haplotype, we reasoned that the 





Figure 2.2: rs51434084 significantly modulates reporter gene expression. Dual 
luciferase reporter assays with haplotypes from A/J, 129S1/SvImJ, and C57BL/6J 
strains, as well as C57BL/6J haplotype with the rs51434084 C > G site-directed 
mutant (SDM) allele, were performed, and firefly/Renilla ratios are shown. Reporter 
clones are grouped by in vivo Zfp30 expression as in Figure 1, with the addition of a 
haplotype generated by SDM of rs51434084 (M→H). (A) Results from assays in 
MLE12 cells show a significant increase in SDM construct compared with the 
C57BL/6J construct. (B) Results from assays in LA4 cells show a significant 








Figure 2.3: Electrophoretic mobility shift assays reveal differential binding of a 
transcription factor at the rs51434084 locus. Biotin-labeled 17-bp double-
stranded DNA oligonucleotides containing contrasting rs51434084 alleles were 
incubated with 4 μg of MLE12 nuclear lysates. Unlabeled probes were incubated at 















To identify candidate proteins that participate in these DNA–protein 
complexes, we used the transcription factor binding site prediction tools TRANSFAC 
and HOCOMOCO to search for known mouse DNA-binding proteins predicted to 
differentially bind to the C57BL/6J and 129S1/SvImJ probe sequences. Multiple 
candidates emerged from this analysis (Table S35), and literature searches revealed 
that two candidates have established roles in immune regulation and have 
repressive transcriptional activity, rendering them priority candidates. ZFP148 (also 
known as ZBP-89, BERF-1, and BFCOL1) has been shown to regulate CXCL5, a 
chemokine similar to CXCL1 in function (Keates et al. 2001). KLF4 (also known as 
GKLF) was associated with endothelial barrier integrity and severity of 
lipopolysaccharide-induced lung injury (Cowan et al. 2010). 
EMSA experiments with a supershift condition did not reveal a supershift with KLF4 
antibody (data not shown). In contrast, addition of ZFP148 antibody produced a 
supershift (Figure 2.S3), indicating that ZFP148 is among the DNA–protein 
complexes identified in Figure 2.3. We detected differential intensity of the 
supershifted band when probing with oligos representing the rs51434084 C or G 
alleles (Figure 2.4, lanes 3 and 6), accompanied by differential intensity of the lower 
band that is reduced by ZFP148 antibody addition (Figure 2.4, lanes 2 and 5). These 
results indicate that ZFP148 is among the nuclear proteins with higher affinity to the 
C57BL/6J probe. 
______________________ 






Figure 2.S3: Electrophoretic mobility shift assay super-shift reveals ZFP148 
binding. Biotin-labeled 17-bp double-stranded DNA oligonucleotides containing the 
C57BL/6J rs51434084 allele was incubated with 4 μg of MLE12 nuclear lysates. 
Super-shift condition incubated with 20 μg ZFP148 antibody. Adobe Photoshop was 
used to adjust image brightness (+88) and contrast (-49). Adobe Illustrator was used 









Figure 2.4: Electrophoretic mobility shift assay supershift reveals differential 
ZFP148 binding. Biotin-labeled 17-bp double-stranded DNA oligonucleotides 
containing contrasting rs51434084 alleles were incubated with 4 g of MLE12 
nuclear lysates. The supershift condition was incubated with 10 g ZFP148 
antibody. White asterisks denote the supershift band. The unmodified image is 













Neutrophil levels in human airways correlate with asthma disease severity 
(Wenzel et al. 2003; Moore et al. 2014), poor response to inhaled corticosteroids 
(Green et al. 2002), and sudden-onset fatal asthma attacks (Sur et al. 1993). In  
COPD, neutrophil-to-lymphocyte ratio (NLR) is associated with disease state, and 
increased NLR is associated with longer hospital stays and higher readmission rates 
(Günay et al. 2014; Duman et al. 2015). Additionally, neutrophil extracellular traps  
are associated with increased airflow limitation among patients with COPD, and 
neutrophilic inflammation leads to decreased lung function (Quint and Wedzicha 
2007; Hoenderdos and Condliffe 2013; Grabcanovic-Musija et al. 2015). In cystic 
fibrosis, neutrophil secretory proteins drive disease states and increase mucus 
production (Mackerness et al. 2008; Gifford and Chalmers 2014; Laval et al. 2016). 
In acute lung injury, neutrophils are a key component to lung damage, and their 
recruitment is controlled by complex chemokine networks (Grommes and Soehnlein 
2011; Williams and Chambers 2014). Genes related to neutrophils and their 
recruitment are also upregulated in early sepsis-induced ARDS (Kangelaris et al. 
2015). These findings indicate that increased understanding of neutrophil 
recruitment to the lung would have broad importance. 
To gain insight into the regulation of neutrophil recruitment, we exploited a 
mouse model of asthma featuring neutrophilic inflammation. In the context of this 
model system, we identified Zfp30 as a candidate regulator of CXCL1 levels and 
neutrophil recruitment (Rutledge et al. 2014). Here, we follow up this finding by 
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identifying a causal variant for the variation in Zfp30 expression, namely 
rs51434084. 
Our reporter assays with Zfp30 promoter constructs provided two main 
findings. First, this 500 bp region successfully recapitulated the twofold range of 
variation in Zfp30 expression we previously characterized in vivo (Rutledge et al. 
2014). Second, allele-swapping of rs5143408 using site-directed mutagenesis 
shows that this variant is the primary driver of the twofold expression difference 
between these strain groups. We also note that in our in vitro reporter assays, the 
expression pattern for CAST/EiJ and PWK/PhJ differed between the two cell lines 
we used (MLE12 and LA4). The expression pattern seen in the LA4 cell line 
(generated from the A/He mouse strain) matched mRNA expression results seen in 
vivo, but the pattern seen in MLE12 (generated from FVB/N mouse strain) did not. 
This suggests that these cell lines differentially express a repressor protein that 
downregulates expression of Zfp30 in CAST/EiJ and PWK/PhJ. Future experiments 
will be directed toward identifying the causal variant(s) and protein(s) responsible for 
this modulation of Zfp30 expression. 
Our EMSA results indicate that ZFP148 is among the transcription factors that 
bind to the rs51434084 locus in the Zfp30 promoter region and thereby regulate 
Zfp30 expression. Thus, we propose that our initial model, in which Zfp30 
expression regulates CXCL1 and neutrophil recruitment (Rutledge et al. 2014), be 
expanded to include ZFP148. ZFP148 has a known role in the negative regulation of 
Cxcl5, a CXCR2 ligand similar to CXCL1, in human colonic epithelial cells (Keates et 
al. 2001). In combination with previous findings, our results suggest that ZFP148 
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downregulates both Cxcl5 and Zfp30. These functions may seem contradictory at 
first, as Zfp30 is proposed to downregulate Cxcl1, but decreased expression of 
Cxcl5 has actually been linked to increased neutrophil recruitment into the lungs in 
an Escherichia coli pneumonia mouse model (Mei et al. 2010) through a mechanism 
involving Duffy antigen receptor for chemokines (DARC)–mediated sequestration of 
CXC chemokines. This mechanism results in a steeper gradient of CXCL1 and 
CXCL2 chemokines between vasculature and lungs. Thus, the function of ZFP148 
proposed here could be cooperative with its known effect on CXCL5 levels. 
ZFP30 is a C2H2 zinc finger protein with domains that suggest DNA-binding 
and KAP-1–binding functions. Wherever ZFP30 binds in the genome, a complex of 
proteins recruited by KAP-1 are predicted to induce heterochromatin domains and 
silence nearby genes (Friedman et al. 1996; Ryan et al. 1999; Schultz et al. 2002; 
Medugno et al. 2005). Specific binding sites for ZFP30 have not yet been identified, 
and additional work is needed to characterize the mechanism of ZFP30-mediated 
control of neutrophil recruitment. Cxcl1 is a priority locus of interest; however, KAP-
1/zinc finger protein complexes could have multiple binding sites and can act over 
tens of kilobases (Groner et al. 2010), so multiple genes may be affected. 
This work contributes to an increased understanding of how Zfp30 is 
regulated as a function of an allelic variant, which we previously showed was linked 
to neutrophils in the airways in a mouse model. Future work examining the 
relevance of the genes/proteins studied here, namely ZFP148 and ZFP30, in 
neutrophil chemotaxis in other model systems and in human patients is a critical 
next step to evaluating the biomedical importance of our findings. Additionally, 
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identification and characterization of additional functional variants that impact 
neutrophil recruitment will further develop our understanding of the complex 
regulatory networks that drive disease severity phenotypes in both model systems 






CHAPTER 3: BASELINE AND IMMUNE RESPONSE CHARACTERIZATION OF A 
ZFP30 KNOCKOUT MOUSE STRAIN 
 
Introduction 
 Neutrophils are a vital participant in the innate immune system’s response to 
pathogens, but the mechanisms through which these cells respond to immune 
challenge are prone to collateral host tissue damage (Nathan 2006). Production of 
reactive oxygen intermediates, degranulation of cytotoxic molecules, and NETosis 
are each effective at killing invading microbes, but they can all damage host tissue 
and drive disease if left unchecked. Neutrophils are also potent signaling cells that 
recruit additional leukocytes to sites of inflammation and participate in complex cross 
talk with other immune cell types (Mantovani et al. 2011).  For these reasons, 
neutrophils drive pulmonary disease severity in acute respiratory distress syndrome 
(ARDS) (Chollet-Martin et al. 1992; Grommes and Soehnlein 2011; Williams and 
Chambers 2014; Kangelaris et al. 2015), chronic obstructive pulmonary disease 
(COPD)(Qiu et al. 2003; Quint and Wedzicha 2007; Hoenderdos and Condliffe 2013; 
Günay et al. 2014; Duman et al. 2015; Grabconovic-Musija 2015), and cystic fibrosis 
(CF) (Mackerness et al. 2008; Gifford and Chalmers 2014).  A growing body of 
evidence also suggests a role for neutrophils in asthma disease severity (Stănescu 
et al. 1996; Jatakanon et al. 1999; Wenzel et al. 1999; Green et al. 2002; Little et al. 
2002; Uddin et al. 2010; Moore et al. 2010).   
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 Dysregulation of the chemokines that attract neutrophils into tissues may tip 
the scale from appropriate innate immune response to unwanted damage.  The CXC 
chemokine family members CXCL8 (IL-8), CXCL1 (KC/Gro-α), CXCL2 (MIP-2/Gro-
β), and CXCL5 (LIX/ENA-78) are all hallmark neutrophil recruitment molecules that 
signal through the chemokine receptor CXCR2 (Charo and Ransohoff 2006).  
Pharmaceutical targeting of CXCR2 has proven effective in reducing airway 
neutrophilia in early chronic pulmonary disease trials (Nair et al. 2012; Moss et al. 
2013; Kirsten et al. 2015; Rennard et al. 2015; Todd et al. 2016; Wats 2017). After 
CXCR2 antagonism, patients with COPD present with fewer neutrophils in sputum 
alongside improved forced expiratory volume (Kirsten et al. 2015; Rennard et al. 
2015). Likewise, cystic fibrosis patients treated with CXCR2 antagonists also 
showed fewer neutrophils and lower amounts of neutrophil elastase in sputum (Moss 
et al. 2013). CXCR2 antagonism also reduced airway neutrophils in mild atopic 
asthmatics and patients with severe or persistent neutrophilic asthma (Nair et al. 
2012; Todd et al. 2016; Watz et al. 2017). 
 To further probe the pathways underlying pulmonary neutrophil recruitment, 
we applied a house dust mite model of asthma to incipient line of the Collaborative 
Cross, a genetics reference population ideal for the study of complex traits (Rutledge 
et al. 2014). This study pointed to Zfp30 as a candidate repressor of CXCL1 and 
neutrophil recruitment to the lungs.  Zfp30 is a C2H2 zinc finger protein with a KRAB 
domain. The C2H2 domains allow ZFP30 to bind to DNA in a sequence specific 
manner, and the KRAB domain recruits the KAP1 transcriptional repressor to these 
binding sites (Friedman et al. 1996). This transcriptional repression proceeds 
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through recruitment of HP1, SETDB1, and histone deacetylases that induce 
heterochromatin formation and silence nearby genes (Ryan et al. 1999; Schultz et 
al. 2002; Medugno et al. 2005; Groner et al. 2010). In this study, we further 
characterize Zfp30 and its role in neutrophil recruitment through generation of a 
CRISPR-Cas9 knockout mouse model for use in ex vivo and in vivo experiments. 
Our results confirm a regulatory effect of Zfp30 on CXCL1 secretion and undercover 
novel connections between Zfp30 and IL-6, blood glucose levels, and multiple organ 
weight phenotypes. 
Materials and Methods 
Generation of Zfp30 Knockout Mice by CRISPR/Cas9 Embryo Microinjection 
 A CRISPR/Cas9 guide RNA (5’-GAATCCAGATACAGCAGTAA(CGG)-3’) was 
designed to target mouse Zfp30 gene near the 5’ end of exon 5. While targeting 
earlier exons would have been preferable, exon 5 was the only region that could be 
targeted with specificity owing to high homology across ZFP family members. Exon 
5 encodes the C2H2 zinc finger domains of ZFP30 that are involved in DNA binding. 
The guide RNA was produced by T7 in vitro transcription and validated in vitro by 
incubating guide RNA, Cas9 enzyme, and plasmid harboring the guide RNA target 
site. This was followed by gel electrophoresis to determine the extent of in vitro 
cleavage activity. A donor oligonucleotide (“Z30-H1-T”: 5’-
GTTTTTCTTCTTTTTGCTTTCAGATCTGGAATCCAGATACAGC[TGA][TAG]GATC
C[TAG]ACCGGTAACGGGTTACTTCCAGAAAAGAATACTTACGAAATTAATCTATC
T-3’) was used for homologous recombination to insert stop codons (brackets) and a 
BamHI restriction site (underlined) at the target site. 
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C57BL/6J females were superovulated by injection with pregnant mare’s 
serum gonadotropin (PMSG) and human chorionic gonadotropin (HCG) and then 
mated with C57BL/6J stud males for zygote production. One-cell embryos were 
collected from the ampulla oviducts the morning after mating and microinjected with 
either “low” or “high” mix, containing, respectively, 20 ng/µl or 100 ng/µl in vitro 
transcribed Cas9 mRNA, 20 ng/µl or 50 ng/µl Zfp30 guide RNA and 100 ng/µl Z30-
H1-T donor oligonucleotide. The microinjected embryos were then implanted into 
pseudopregnant recipients. 
Fourteen live pups born from microinjected embryos were screened by 
polymerase chain reaction (PCR) amplification of the Zfp30 target site followed by 
digestion of the PCR product with BamHI restriction enzyme. The BamHI restriction 
site was detected in nine animals. Two founders with apparent biallelic insertion of 
the BamHI restriction site were mated to C57BL/6J animals for germline 
transmission of the targeted allele.  
The founder animals harboring Zfp30 mutations were screened for mutations 
at 10 potential off-target sites (Supplementary Table 1) predicted by crispr.mit.edu in 
October 2013. Each potential off-target site was PCR amplified and products were 
analyzed by T7endo1 assay. Founders chosen for line establishment were further 
analyzed by Sanger sequencing of PCR products for all 10 off-target sites. A single 
founder line was subsequently backcrossed to C57BL/6J again to remove detected 
off-target mutations. The resulting colony was maintained via heterozygous matings. 
In the initial stages of breeding, genotyping of Zfp30 knockout mice was 
performed using allele-specific PCR. Primer sets were designed to specifically target 
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either the Zfp30+/+ (Fwd: GGGCTGCTAAGTCCATTCAG; Rev: 
GGAAGTAACCCGTTACTGCTG) or Zfp30-/-  (Fwd: GGGCTGCTAAGTCCATTCAG; 
Rev: CGTTACCGGTCTAGGATCCT) allele.  We later transitioned to a proprietary 
qPCR-based genotyping protocol through Transnetyx (Cordova, TN). 
qPCR for Zfp30 Quantification in the Knockout Strain 
To quantify Zfp30 gene expression level in Zfp30+/+ and Zfp30-/- mice, we 
designed primer sets that specifically quantify the Zfp30+/+ allele (Fwd: 
TGTTGGAACAAGGGAAGGAG; Rev: GTAACCCGTTACTGCTGTAT) or specifically 
quantify the Zfp30-/- allele (Fwd: TGTTGGAACAAGGGAAGGAG; Rev: 
CGGTCTAGGATCCTATCAGCT). qPCR reactions were carried out using iTaq 
Universal SYBR Green Supermix (Bio-Rad; Hercules, CA USA).  
Complete Blood Count Assays and Blood Glucose Testing 
For complete blood counts, blood was collected in EDTA tubes and stored on 
ice for a minimal amount of time before processing via a ProCyte Dx Hematology 
Analyzer.  
For blood glucose measurements, blood was collected, and serum was 
separated via centrifugation using Microtainer tubes with lithium heparin (BD). Blood 
glucose measurements were taken using an Alfa Wasserman Vet Axcel Chemistry 
System.  
Neutrophil Recruitment Models 
LPS challenge: Intratracheal instillation of LPS from E. coli (LIST Biologicals) 
into lungs of Zfp30+/+ and Zfp30-/- mice was carried out at a dose of 0.3 mg per kg of 
bodyweight using the method of Limjunyawong, Mock, and Mizner (Limjunyawong et 
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al. 2015).  Bronchoalveolar lavage fluid was collected between 8 and 48 hours after 
exposure, and differential cell counts in bronchoalveolar lavage fluid were 
performed. Aliquots of BALF were saved for cytokine quantification. Oropharyngeal 
aspiration of LPS from E. coli (LIST Biologicals) into lungs of Zfp30+/+ and Zfp30-/- 
mice was carried out with 5µg LPS in 40µl PBS. 
Sensitization to House dust mite allergen Der p 1: Zfp30+/+ and Zfp30-/- mice 
were sensitized with 10 µg Der p1 administered through intra-peritoneal injection (in 
100 µl of PBS) on days 0 and 7 of the experiment, and a 50 µg Der p1 challenge 
was administered on day 15 of the experiment (Kelada et al. 2011). Mice were 
sacrificed 48-72 hours after challenge, and differential cell counts in bronchoalveolar 
lavage fluid were performed. Aliquots of BALF were saved for cytokine 
quantification.  
Ozone exposure: Zfp30+/+ and Zfp30-/- mice were exposed to filtered air, 1 
ppm ozone, or 2 ppm ozone for three hours (Smith et al. 2018). Bronchoalveolar 
lavage fluid was collected 24 hours after exposure, and differential cell counts in 
bronchoalveolar lavage fluid were performed.  
MTEC Culture  
Mouse tracheal epithelial cell (MTEC) cultures were generated and cultured 
according to a previously established protocol (You and Brody 2013). Tissues 
isolated from 4 week old mice were grown using PluriQ differentiation media and 
plated in 12 well plates with Transwell inserts.  Cells were maintained at air-liquid 
interface for a minimum of three weeks to allow for differentiation.  LPS and FLA-ST 
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exposures were carried out at 10µg/mL in 100µl of PBS added to the apical surface 
of MTECs for 24h.  
Luminex Assays 
Cytokines in bronchoalveolar lavage fluid or PBS used in MTEC LPS 
exposures were measured using Milliplex assays (Millipore, Billerica, MA) according 
to manufacturer’s instructions. 
Histology 
 Histological preparation and analysis of lungs was carried out using 
previously described methods (Donoghue et al. 2017). Briefly, left lung lobes were 
fixed in formalin and cut in cross-section starting at the hilum and 2mm apart along 
the main stem bronchus. Sections were embedded in paraffin and stained with 
Hematoxylin and eosin (H&E) stain. Images were captured on an Olympus BX605F 
microscope with CellSens Standard software.  
Results 
We sought to investigate the function of Zfp30 through a CRISPR-Cas9 
mediated in vivo knockout model. Of fourteen pups born from microinjected 
embryos, nine had successful insertion of our knockout cassette, and two founders 
with biallelic insertion were mated to C57BL/6J for germline transmission of the 
targeted allele.  These founder animals were screened for ten potential off-target 
insertions, and a single founder was subsequently backcrossed once more to 
C57BL/6J to establish our knockout colony.  Throughout the maintenance of this 
colony, transmission ratio distortion (TRD) was a periodic issue. A significant 
depletion of knockouts was apparent in the early stages of breeding, and this 
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depletion was initially overcome via selective breeding of mice that produced normal 
litters. TRD appeared again after several generations of breeding, however. Our 
total genotype ratios for the history of the colony reveal a significant depletion of 





Table 3.1: Genotype ratios reveal Transmission Ratio Distortion among the 
Zfp30 knockout colony. Genotypes of all mice born from Zfp30+/- x Zfp30+/- 
breeding pairs were tallied, and observed genotype ratios are reported along with 
the expected Mendelian genotype ratio. A !" calculation was performed to test the 


























Because no reliable antibody for mouse ZFP30 exists, we initially queried the 
effect of Zfp30 knockout at the RNA level. We designed a qPCR-based approach to 
specifically quantify expression of either the Zfp30+/+ allele or the CRISPR-Cas9 
modified Zfp30-/- allele. We detected expression of only the Zfp30+/+ allele in WT 
mice, only the Zfp30-/- allele in KO mice, and intermediate expression of the two 
alleles in heterozygous mice (Figure 3.1A). 
Baseline Phenotyping 
As a family, the KRAB domain-containing C2H2 zinc finger proteins are 
thought to play an important role in differentiation and development (Urrutia 2003; 
Lupo et al. 2013). To asses the impact that a whole body knockout of Zfp30 might 
have on development, we tracked total body weight in a population of Zfp30+/+, 
Zfp30+/-, and Zfp30-/- mice (derived from Zfp30+/- x Zfp30+/- matings) between four 
and eight weeks of age, and this revealed no significant differences by genotype 
(data not shown).  We also assayed the weights of lungs, pancreases, spleens, and 
livers in Zfp30+/+ and Zfp30-/- mice. We detected no significant differences in lung or 
pancreas weights, but Zfp30-/- mice exhibit significantly smaller spleens and livers 
relative to total body weight (Figure 3.1 B and C), and we additionally see 
significantly reduced blood glucose levels among Zfp30-/- mice, suggesting an 
impact on pancreas function (Figure 3.1 D). Complete blood count (CBC) assays did 
not reveal any significant reproducible differences in red blood cell or circulating 
leukocyte phenotypes between Zfp30+/+ and Zfp30-/- samples (data not shown). 





Figure 3.1: Baseline phenotyping reveals impacts of Zfp30 on spleen weight, 
liver weight, and blood glucose levels. (A) Allele-specific qPCR reveals 
expression of only the inserted Zfp30-/- allele among KO mice and intermediate 
expression of the two alleles among Zfp30+/- mice. Reactions for each allele were 
carried out on samples from mice of each genotype, and results are normalized to 
homozygous expression level. (C-D) Weights of excised organs reveal significantly 
smaller spleens (C) and livers (D) among Zfp30-/- mice. (E) Blood glucose 




lungs to investigate any obvious differences in the airways, alveoli, or vasculature 
and detected no striking differences (Figure 3.2).  
Ex vivo Mouse Tracheal Epithelial Cell Cultures 
Given our previous results indicating a correlation between Zfp30 expression 
and innate immune response in the lung (Rutledge et al. 2014), we tested innate 
immune responses in mouse tracheal epithelia cultures (MTECs) from Zfp30+/+ and 
Zfp30-/- mice. This system was particularly well suited to study the impact of Zfp30 
knockout on neutrophil recruitment, because recent single-cell RNA sequencing 
(RNA-seq) data suggests expression of Zfp30 across a broad array of cell types in 
the airway epithelium (Plasschaert et al. 2018). Additionally, we previously showed 
that MTEC cultures have high expression of Zfp30 and that perturbation of Zfp30 
expression with siRNAs results in increased CXCL1 production following LPS 
exposure in a mouse airway epithelia cell line (Rutledge et al. 2014).  We saw 
significant differences in CXCL1 secretion in the basolateral media of these cultures 
following LPS stimulation, indicating that knockout of Zfp30 produced the expected 
impact initially observed in the CC and MLE12 airway epithelial cell line (Rutledge et 
al. 2014) (Figure 3.3 A). We also observe differential CXCL1 secretion in response 
to Flagellin protein (FLA-ST), a TLR5 ligand. These experiments additionally 
revealed significantly decreased secretion of IL-6 on the apical surface of Zfp30-/- 
MTEC cultures in response to LPS and FLA-ST (Figure 3.3 B). To survey potential 
differences in airway epithelial cell type ratios among Zfp30+/+ and Zfp30-/- MTEC 
cultures, we carried out qPCR for cell type-specific markers: Foxj1 (ciliated cells), 




Figure 3.2: Histological analysis reveals no striking phenotypic differences among the Zfp30 knockout colony. 
H&E staining was carried out on lung sections from Zfp30+/+ and Zfp30-/- mice. No significant differences are seen in large 












Figure 3.3: Zfp30 modulates CXCL1 and IL-6 secretion in cultured MTECs. MTEC cultures were generated from 
Zfp30+/+ and Zfp30-/- mice and maintained at air-liquid interface. LPS and FLA-ST exposures induce significantly more 
CXCL1 (A) and significantly less IL-6 (B) secretion in response to TLR4 (LPS) and TLR5 (FLA-ST) ligands. Exposures 







no differences in cell type ratios between Zfp30+/+ and Zfp30-/- cultures (data not 
shown).	
In vivo Lung Inflammation Phenotypes in Zfp30-/- mice 
Zfp30 was identified as a candidate regulator of CXCL1 levels and neutrophils 
in bronchoalveolar lavage fluid in the context of a model of allergic airway disease 
(Rutledge et al. 2014).  As a direct follow-up to these experiments, we utilized the 
same house dust mite model of allergic airway disease in Zfp30+/+ and Zfp30-/- mice 
to further probe the connection between Zfp30 and neutrophil recruitment.  We saw 
no significant differences in neutrophil counts or CXCL1 in bronchoalveolar lavage 
fluid (BALF) 48 or 72 hours post-challenge (Figure 3.4 A-B). 
Our allergic airway disease model is dominated by eosinophilia. To test for 
differences in CXCL1 secretion or neutrophil recruitment into the lungs in the context 
of neutrophil-dominated immune responses, we employed LPS and ozone exposure 
models. These models induce a much more robust neutrophilic airway recruitment 
than the HDM model, so differences in chemotactic signaling may be more apparent. 
Intratracheal instillation of LPS does not reveal a significant difference in neutrophil 
or CXCL1 levels in BALF (Figure 3.5 A-B). We did however note significant impacts 
on IL-6 in BALF in a subset of our LPS experiments (Figure 3.5 C). We also see no 
significant differences in neutrophilia utilizing 1ppm or 2ppm ozone exposures 
(Figure 3.6). 
Discussion 
 Further study of the underlying genes that preclude or contribute to host 





Figure 3.4: House dust mite allergen challenge in Zfp30+/+ and Zfp30-/- mice reveals no significant difference in 
neutrophil count or CXCL1 concentration in BALF. Zfp30+/+ and Zfp30-/- mice were sensitized to and challenged with 
HDM allergen, and effects on neutrophil counts (A) and CXCL1 concentration (B) in BALF were monitored 48 and 72 
hours after challenge. Cell count results are the combined data of two experiments. Neutrophil levels were assayed via 







Figure 3.5: LPS challenge in Zfp30+/+ and Zfp30-/- mice reveals a significant difference in IL-6 concentration but 
not neutrophil count or CXCL1 concentration in BALF. Intratracheal LPS administration in Zfp30+/+ and Zfp30-/- mice 
reveals no impact on neutrophil counts (A) or CXCL1 concentration (B), but a significant impact on IL-6 (C) concentration 
is observed.  Neutrophil counts reported are from a single intratracheal administration and are representative of 2 OPA 
administration experiments and 2 intratracheal administration experiments. CXCL1 and IL-6 results are the combined data 
from two OPA administration experiments. Neutrophil levels were assayed via differential cell counts, and cytokine 









Figure 3.6: Ozone exposure of Zfp30+/+ and Zfp30-/- mice reveals no significant 
impact on neutrophil counts in BALF. A three-hour exposure of Zfp30+/+ and 
Zfp30-/- mice to 2 ppm ozone reveals no significant differences in neutrophils in 
BALF. Results are representative of a single 2ppm exposure and a single 1ppm 
exposure. Neutrophil levels were assayed via differential cell counts, and cytokine 







health and economic benefits, as neutrophil-driven pulmonary diseases are common 
and lead to increased healthcare utilization. We confirmed in this manuscript a 
regulatory impact of Zfp30 on CXCL1 secretion in an ex vivo model of airway 
epithelia and revealed a novel impact of Zfp30 on epithelia-secreted IL-6.  
Interestingly, we saw opposite directions of effect in CXCL1 and IL-6.  CXCL1, a 
hallmark neutrophil chemokine, was significantly up-regulated in Zfp30-/- epithelia 
after immune stimulus. IL-6, however, is significantly down-regulated in the same 
LPS-stimulated MTEC cultures.  This may at first seem contradictory, as IL-6 is 
typically thought of as a pro-inflammatory signaling molecule, but IL-6 has been 
implicated in the clearance of neutrophils and down-regulation of CXCL1 in a model 
of acute inflammation (Fielding et al. 2008).  IL-6 activation of STAT3 is thought to 
comprise a checkpoint in acute inflammation in which a neutrophil recruitment 
response transitions to a more monocyte-dominated response (Fielding et al. 2008), 
and our results suggest that Zfp30 may play some role in this checkpoint.  
Our cell type-specific qPCR results with Foxj1, Krt5, Scgb1a1, and Muc5ac 
suggest that the impacts of Zfp30 on cytokine secretion are not due to differences in 
the abundance of cytokine-secreting cells.  The observation that Zfp30 leads to 
differential cytokine secretion in response to both TLR4 and TLR5 ligands may imply 
that ZFP30 targets some shared member of the downstream signaling machinery of 
these receptors.  Follow-up experiments to probe specific shared members of these 
signaling pathways or to assay genome-wide expression in Zfp30-/- data may give 
further insights into the targets of ZFP30-mediated repression. 
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 In contrast to our ex vivo results, our in vivo experiments largely did not reveal 
significant differences in chemokine secretion or neutrophil recruitment.  We 
observed an impact on IL-6 secretion in a subset of our in vivo results, but we did 
not see reproducible effects on CXCL1 or neutrophil levels. One potential 
explanation is that Zfp30 may have a modest effect on CXCL1 secretion in vivo.  Our 
ex vivo cytokine measurements represent an accumulated difference in CXCL1 and 
IL-6 secretion in cell culture media over a 24 hour period; at any particular snapshot 
of time in vivo, the difference in CXCL1 or IL-6 levels may not be large enough to 
produce an observable effect with our BALF analysis methods.  Another potential 
explanation is the genetic background that our knockout was generated on. 
C57BL/6J has a known mutation in Nlrp12 that impacts neutrophil recruitment and 
CXCL1 production by leukocytes (Ulland et al. 2016; Hornick 2017). If Zfp30 impacts 
CXCL1 secretion by neutrophils, this may have played a role in its original discovery 
in the CC and may not be apparent in C57BL/6J mice.  Introducing a knockout into 
an already-mutated cytokine secretion pathway may mask the effects of the 
knockout. As a follow-up to the results presented here, one could consider a Zfp30 
knockout or knockdown in an alternate mouse strain.  If Nlrp12 masks the effect of 
Zfp30 on neutrophil recruitment in C57BL/6J, use of another mouse strain could 
facilitate a more in-depth investigation of ZFP30’s role in neutrophil recruitment in 
vivo. 
 Our results additionally revealed effects of ZFP30 loss on spleen weight, liver 
weight, and blood glucose levels.  Zfp30 is differentially expressed in the pancreatic 
beta cells of type-2 diabetes patients (Lawlor 2017), so the results presented here 
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may warrant a follow-up investigation into the impact of Zfp30 in a mouse model of 
diabetes. Moving forward, the role of Zfp30 on development and pancreas function 
should be investigated more closely.  RNA-seq and ATAC-seq in MTEC cultures, 
spleens, livers, and pancreases of Zfp30+/+ and Zfp30-/- mice would help to identify 
the specific targets of ZFP30-mediated repression in each of these tissues.  RNA-
seq will reveal genes that are differentially expressed in the Zfp30-/- mice, and ATAC-
seq will provide information on the chromatin states of these tissues.  Zfp30-/- mice 
likely have altered chromatin states near genes that are directly repressed by 
ZFP30, as the KAP1-mediated heterochromatin domains at those sights will not be 
maintained via ZFP30 binding.   
 The cause of our periodic TRD phenotype remains unclear, though there is 
precedent for zinc finger protein knockout mice to display some degree of embryonic 
lethality. Knockout of Zfp57, a C2H2 ZFP with a KRAB domain, impacts the 
establishment and maintenance of critical DNA methylation imprints, and disruption 
of this imprinting leads to death (Li et al. 2008). It is possible that we are observing a 
phenotype with incomplete penetrance or variable expressivity due to Zfp30’s impact 
on the local chromatin landscape of the causal gene(s).  If there is epigenetic 
inheritance of Zfp30 chromatin effects, this could potentially explain why the TRD 
disappeared after selective breeding.  Additional generations of breeding may have 
allowed slow erosion of ZFP30-maintained heterochromatin domains among 
heterozygous mice used for breeding given that heterozygous mice have 





CHAPTER 4: DISCUSSION 
	
Many polymorphisms contribute to variation in a complex trait, and 
identification of these variants can be difficult due to intricate genetic architecture 
(Lander and Schork 1994).  Genetics reference populations like the Collaborative 
Cross make it easier to tease apart the underlying mechanisms of disease-related 
phenotypes through use of a large number of inbred lines, particularly in the context 
of studies with both treatment and control groups. In this dissertation, I follow up on 
a QTL mapping study in the Collaborative Cross (Rutledge et al. 2014) that identifies 
Zfp30 as a candidate regulator of CXCL1 secretion levels and neutrophil recruitment 
to the lung.  In Chapter 2, I identify a causal variant underlying the bulk of variation in 
Zfp30 expression. In Chapter 3, I explore the role of Zfp30 in cytokine secretion and 
neutrophil recruitment to the airways using a whole body knockout mouse model, 
and I uncover a novel role of Zfp30 in IL-6 regulation. 
A large proportion of genetic variants associated with disease are found in 
regulatory regions of the genome and overlap transcription factor binding sites 
(Maurano et al. 2012). In Chapter 2, I show that this is the case with rs51434084, a 
SNP underlying the Zfp30 eQTL identified in the Collaborative Cross study 
(Rutledge et al. 2014).  I utilize luciferase assays and site-directed mutagenesis in a 
candidate regulatory region of Zfp30 to test the impact that specific SNPs have on 
expression, and I conduct EMSA experiments to identify the mechanism through 
which candidate SNPs impact transcription. I find that variation at rs51434084 
	
	 56 
produces a two-fold difference in expression level of Zfp30 via differential binding of 
ZFP148, a known transcriptional repressor. 
Identifying the mechanisms that produce differential expression is not always 
straightforward, however. rs51434084 accounts for the difference in Zfp30 
expression between the high (A/J, NOD/LtJ, NZO/H1LtJ, 129S1/SvImJ) and 
moderate (C57BL/6J and WSB/EiJ) expressing strains described in Chapter 2, but 
the mechanism that differentiates the moderate and low (CAST/EiJ and PWK/PhJ) 
expressing groups remains unclear. Using site directed mutagenesis and luciferase 
assays, I find that modification of any of the 6 SNPs shared by the low expression 
group in our cloned promoter region (Table 2.1) produces a shift from moderate to 
low expression in a C57BL/6J promoter (Figure 4.1).  We initially expected a single 
SNP to explain the full difference between the moderate and low expression groups 
or for multiple SNPs to each modulate expression by a smaller fraction.  Our results, 
however, suggest that variation at any of these six shared SNPs that span a ~120bp 
region is sufficient to produce the difference in expression between the moderate 
and low Zfp30 expression groups. This suggests that each SNP impacts the same 
mechanism of Zfp30 regulation. Future experiments could include combinations of 
SNPs in site-directed mutagenesis or prediction of upstream binding of transcription 
factors with mechanisms of action that are impacted by local DNA sequence.   
In Chapter 3, I utilize a knockout mouse model to explore the role of Zfp30 in 




Figure 4.1: SNPs shared among low-expressing promoters significantly 
modulate Zfp30 expression level. Dual luciferase reporter assays with haplotypes 
from 129S1/SvImJ, C57BL/6J, CAST/EiJ, and PWK/PhJ strains, as well as 
C57BL/6J haplotype with site-directed mutagenesis of the rs211739374 (1), 
rs211739374 (2), rs252419650 (3), rs578896492 (4), rs581321876 (5), and 
rs239071968 (6) sites to match the low expressing CAST/EiJ and PWK/PhJ strains  
were performed, and firefly/Renilla ratios are shown. Reporter clones are grouped by 
in vivo Zfp30 expression, with the addition of haplotypes generated by SDM (M→L).  







important regulatory role for Zfp30 in the signaling pathways that modulate 
neutrophilia in the airways.  Zfp30 impacts CXCL1 secretion, which is a known 
chemotactic factor for neutrophils. I also uncover a novel effect of Zfp30 on IL-6 
production, which indicates that Zfp30 may play a role in the eventual clearance of 
neutrophils. However, our in vivo results reveal no significant differences in 
neutrophil recruitment as assayed by differential cell counts from BALF. 
It is not typically clear how many genes contribute to complex phenotypes in 
disease, and networks of epistasis further complicate this genetic architecture (Shao 
et al. 2008).  Thousands of polymorphisms that individually explain less than 1 
percent of variation may underlie a complex phenotype (Goddard et al. 2016). With 
this in mind, it may not be surprising that the knockout of Zfp30 does not produce a 
striking effect on neutrophil level in the lung.  Zfp30 is likely one of multiple 
regulators of CXCL1 and IL-6, CXCL1 is only one of several potent CXCR2 ligands, 
and CXCR2 is only one of multiple receptors that impacts neutrophil chemotaxis. 
This signaling complexity is compounded by the complications that can arise when 
choosing a single mouse strain to test a knockout in. C57BL/6J has known 
mutations that impact CXCL1 expression in leukocytes (Ulland et al. 2016, Hornick 
2017), and epistasis can have significant buffering effects in complex gene networks 
(Shao et al. 2008). All of these factors, together with normal technical variation in in 
vivo experiments, may mask subtle differences in neutrophil recruitment in our 
knockout colony.  Our ex vivo results together with the result from the Collaborative 
Cross (Rutledge et al. 2014) suggest that Zfp30 does have some effect on neutrophil 
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levels in the lung, even if Zfp30 knockout does not cause a statistically significant 
difference upon immune challenge in vivo. 
An additional aim of this body of work was to identify targets of ZFP30-
mediated repression on a genome-wide scale. A comprehensive exploration of 
ZFP30 targets would ideally include both RNA-seq and ChIP-seq analyses. RNA-
seq analysis when Zfp30 is overexpressed or knocked down will reveal the 
downstream transcriptional effects of ZFP30-mediated repression.  ChIP-seq will 
reveal ZFP30 binding sites, and genes near those binding sites are the likely 
candidates for direct repression by ZFP30 due to the mechanism of KAP-1 
heterochromatin domain spreading.  Together, these analyses will identify direct 
functional targets of ZFP30-mediated repression.  ChIP-seq alone does not reveal 
how far the ZFP30-mediated heterochromatin domains spread and does not quantify 
the effect that these heterochromatin domains have on expression of nearby genes.  
RNA-seq alone allows for the possible identification of indirect targets if ZFP30 
modulates the expression of any transcription factors. 
However, this aim of the project has proven difficult to accomplish. ChIP-seq 
requires the ability to probe the protein of interest with an antibody, and we were 
unable to validate any commercially available ZFP30 antibodies. To work around 
this, we attempted to overexpress HA and eGFP-tagged ZFP30 proteins in mouse 
airway epithelia cell lines. We utilized constructs with each tag at either the N or C 
terminus of Zfp30, and we attempted this overexpression in seven cell lines. We 
were able to successfully detect expression of tag control vectors at the protein 
level, but, ultimately, we were unable to achieve tagged overexpression of ZFP30 in 
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a mouse cell line at the protein level.  This prevented us from directly identifying 
ZFP30 binding sites via ChIP-seq, and this prevented us from quantifying the 
protein-level effect of Zfp30 shRNAs for knockdown experiments.  Future efforts to 
identify ZFP30 binding sites could involve ATAC-seq or H3k9me3 ChIP-seq when 
Zfp30 is over-expressed or knocked down to assess heterochromatin domains that 
increase or decrease along with Zfp30 expression level.  
RNA-seq experiments using MTEC cultures from Chapter 3 are underway. 
Zfp30+/+ and Zfp30-/- samples at baseline and after LPS exposure will be assessed 
for differentially expressed genes. The protein-level cytokine results in Chapter 3 
suggest that we may see a significant impact on Cxcl1 and Il-6 expression, but the 
data may reveal a more complex signaling network than we can currently predict. 
Genes that are differentially expressed across treatment groups will reveal the 
overarching signaling pathways that are activated in MTECs upon LPS exposure, 
and any genes within these pathways that are differentially expressed across 
genotypes are likely targets of ZFP30-mediated repression that impact neutrophilia.  
If no genes upstream of Cxcl1 or Il-6 are impacted by Zfp30 knockout, it may 
suggest that Cxcl1 is a direct target of KAP-1 mediated repression.  The direction of 
effect seen in IL-6 secretion, however, suggests that is not directly repressed in 
Zfp30-/- mice. If any immune signaling molecules are differentially expressed that we 
have not tested at the protein level, we may revisit the in vivo or ex vivo models for 
follow-up experiments. This RNA-seq analysis may also provide leads on any roles 
that Zfp30 plays in development or other disease contexts. 
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As the field of genetics shifts more and more toward large-scale mapping 
experiments with genomic data, follow-up studies of candidate genes will become 
increasingly important for understanding the mechanisms that underlie disease. In 
aggregate, this dissertation represents the follow-up characterization of a candidate 
gene identified in QTL mapping studies of immune response phenotypes in the CC. 
Roadblocks in each chapter of the project highlight the intricacies of complex 
disease traits and reveal the difficulty in fully characterizing the mechanisms that 
modulate these traits.  Chapter 2 is a journey from large-scale QTL findings to the 
identification of a specific polymorphism that underlies variation in expression.  
Chapter 3 is a functional characterization of Zfp30 after in vivo and ex vivo immune 
challenge to assess the impact that variation in Zfp30 expression might have on 
disease. Each of these chapters expands the known Zfp30 signaling network and its 
downstream impact.  The findings presented here have implications for a number of 
pulmonary diseases, and it is likely that Zfp30 plays a role in any disease context in 
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